vs
Profound Medical Corp.（PROF）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Rocky Mountain Chocolate Factory, Inc.的季度营收约是Profound Medical Corp.的1.3倍（$7.5M vs $6.0M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -136.8%，领先134.7%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
PROF vs RMCF — 直观对比
营收规模更大
RMCF
是对方的1.3倍
$6.0M
净利率更高
RMCF
高出134.7%
-136.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.0M | $7.5M |
| 净利润 | $-8.2M | $-155.0K |
| 毛利率 | 66.8% | 34.0% |
| 营业利润率 | -123.3% | 1.1% |
| 净利率 | -136.8% | -2.1% |
| 营收同比 | — | -4.4% |
| 净利润同比 | — | 81.7% |
| 每股收益（稀释后） | $0.27 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PROFRMCF
| Q4 25 | $6.0M | $7.5M | ||
| Q3 25 | $5.1M | $6.8M | ||
| Q2 25 | $2.0M | $6.4M | ||
| Q1 25 | $2.3M | $8.9M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $7.3M |
净利润PROFRMCF
| Q4 25 | $-8.2M | $-155.0K | ||
| Q3 25 | $-8.0M | $-662.0K | ||
| Q2 25 | $-15.7M | $-324.0K | ||
| Q1 25 | $-10.7M | $-2.9M | ||
| Q4 24 | — | $-847.0K | ||
| Q3 24 | — | $-722.0K | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $-1.6M |
毛利率PROFRMCF
| Q4 25 | 66.8% | 34.0% | ||
| Q3 25 | 77.7% | 23.6% | ||
| Q2 25 | 81.7% | 31.1% | ||
| Q1 25 | 79.2% | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
营业利润率PROFRMCF
| Q4 25 | -123.3% | 1.1% | ||
| Q3 25 | -176.2% | -7.0% | ||
| Q2 25 | -696.9% | -2.3% | ||
| Q1 25 | -477.0% | -30.3% | ||
| Q4 24 | — | -8.9% | ||
| Q3 24 | — | -14.3% | ||
| Q2 24 | — | -25.4% | ||
| Q1 24 | — | -21.7% |
净利率PROFRMCF
| Q4 25 | -136.8% | -2.1% | ||
| Q3 25 | -157.7% | -9.7% | ||
| Q2 25 | -792.3% | -5.1% | ||
| Q1 25 | -458.1% | -32.5% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -25.9% | ||
| Q1 24 | — | -21.9% |
每股收益（稀释后）PROFRMCF
| Q4 25 | $0.27 | $-0.02 | ||
| Q3 25 | $0.26 | $-0.09 | ||
| Q2 25 | $0.52 | $-0.04 | ||
| Q1 25 | $0.36 | $-0.38 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $641.0K |
| 总债务越低越好 | $4.5M | — |
| 股东权益账面价值 | $66.4M | $6.0M |
| 总资产 | $77.5M | $20.7M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资PROFRMCF
| Q4 25 | $59.7M | $641.0K | ||
| Q3 25 | $24.8M | $2.0M | ||
| Q2 25 | $35.2M | $893.0K | ||
| Q1 25 | $46.4M | $720.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $973.0K | ||
| Q2 24 | — | $637.0K | ||
| Q1 24 | — | $2.1M |
总债务PROFRMCF
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PROFRMCF
| Q4 25 | $66.4M | $6.0M | ||
| Q3 25 | $32.1M | $6.1M | ||
| Q2 25 | $39.3M | $6.7M | ||
| Q1 25 | $50.8M | $7.0M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | — | $10.5M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | $10.6M |
总资产PROFRMCF
| Q4 25 | $77.5M | $20.7M | ||
| Q3 25 | $42.3M | $22.3M | ||
| Q2 25 | $49.7M | $20.1M | ||
| Q1 25 | $60.9M | $21.2M | ||
| Q4 24 | — | $21.6M | ||
| Q3 24 | — | $21.1M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $20.6M |
负债/权益比PROFRMCF
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.3M |
| 自由现金流率自由现金流/营收 | — | -16.9% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PROFRMCF
| Q4 25 | $-6.6M | $-1.2M | ||
| Q3 25 | $-9.6M | $-488.0K | ||
| Q2 25 | $-13.7M | $350.0K | ||
| Q1 25 | $-8.3M | $1.2M | ||
| Q4 24 | — | $-2.1M | ||
| Q3 24 | — | $-3.5M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | — | $129.0K |
自由现金流PROFRMCF
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | — | $182.0K | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-352.3K |
自由现金流率PROFRMCF
| Q4 25 | — | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -72.6% | ||
| Q2 24 | — | -40.2% | ||
| Q1 24 | — | -4.9% |
资本支出强度PROFRMCF
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PROF
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
